What is the role of LDL-C in the development of ASCVD?
Speaker: Prof. Brian A. Ference, Professor and Director in Translational Therapeutics
Which group of patients are at risks of developing ASCVD?
Speaker: Prof. Kausik K Ray, Professor of Public Health and Honorary Cardiology
Emerging therapeutic options in lipid management: from theory to practice
Speaker: Dr. Hani Sabbour, MD FACC, FHRS
Time to Act for ACS patients
Speaker: Prof. Lale Tokgozoglu, Past President - European Atherosclerosis Society